LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.20% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 4.20%, a 2.44% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-03-31 was 3.60%, a 10.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-09-30 was 3.70%, a 15.91% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 4.10%, a 4.65% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 1.90%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.20% 10-Q · filed 2026-08-07 | 3.60% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 3.60% 10-Q · filed 2026-05-08 | ||||
| 2025-09-30 | 3.70% 10-Q · filed 2025-11-07 | 4.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 4.10% 10-Q · filed 2026-08-07 | 4.00% 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | 4.00% 10-Q · filed 2026-05-08 | ||||
| 2024-09-30 | 4.40% 10-Q · filed 2025-11-07 | 4.30% 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 4.30% 10-Q · filed 2025-08-08 | 4.30% 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 4.30% 10-Q · filed 2025-05-09 | ||||
| 2023-09-30 | 4.30% 10-Q · filed 2024-11-08 | 4.10% 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | 3.90% 10-Q · filed 2024-08-07 | 4.10% 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | 4.10% 10-Q · filed 2024-05-08 | ||||
| 2022-09-30 | 2.80% 10-Q · filed 2023-11-09 | 2.90% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 3.00% 10-Q · filed 2023-08-09 | 3.00% 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 1.60% 10-Q · filed 2023-05-08 | ||||
| 2021-09-30 | 0.80% 10-Q · filed 2022-11-08 | 0.50% 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | 0.90% 10-Q · filed 2022-08-09 | 0.50% 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 0.50% 10-Q · filed 2022-05-09 | ||||
| 2020-09-30 | 3.00% 10-Q · filed 2021-11-09 | 0.30% 10-Q · filed 2020-11-06 | 1.00% 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | 0.40% 10-Q · filed 2021-08-03 | 1.10% 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | 1.40% 10-Q · filed 2021-05-06 | ||||
| 2019-09-30 | 1.60% 10-Q · filed 2020-11-06 | 2.40% 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | 1.90% 10-Q · filed 2020-08-07 | 2.40% 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | 2.50% 10-Q · filed 2020-05-08 | ||||
| 2018-09-30 | 2.80% 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | 2.80% 10-Q · filed 2019-08-08 | 2.80% 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | 2.70% 10-Q · filed 2019-05-09 | ||||
| 2017-09-30 | 2.00% 10-Q · filed 2018-11-08 | 2.10% 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | 2.10% 10-Q · filed 2018-08-08 | 2.10% 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | 2.10% 10-Q · filed 2018-05-09 | ||||
| 2016-09-30 | 1.30% 10-Q · filed 2017-11-09 | 1.50% 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | 1.70% 10-Q · filed 2017-08-09 | 1.50% 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | 1.50% 10-Q · filed 2017-05-09 | ||||
| 2015-09-30 | 2.00% 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | 1.70% 10-Q · filed 2016-11-14 | 1.80% 10-Q · filed 2016-11-14 | |||
| 2015-03-31 | 1.80% 10-Q · filed 2016-11-14 | ||||
| 2014-12-31 | 1.90% 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | 1.90% 10-Q · filed 2015-11-09 | 1.90% 10-Q · filed 2015-11-09 |